|
WO2021074261A1
|
|
B-lymphocyte specific amatoxin antibody conjugates
|
|
WO2020234461A1
|
|
Antibody drug conjugates with cleavable linkers
|
|
WO2020216947A1
|
|
Amatoxin antibody-drug conjugates and uses thereof
|
|
WO2020120525A1
|
|
Synthesis of (s)-6-hydroxytryptophan and derivatives thereof
|
|
AU2019312801A1
|
|
Humanized antibodies against PSMA
|
|
CN111989122A
|
|
Targeted amatoxin conjugates for the treatment of solid tumors
|
|
AU2018335378A1
|
|
PSMA-targeting amanitin conjugates
|
|
US2021061805A1
|
|
Novel method for synthesizing amanitins
|
|
EP3558390A1
|
|
Amanitin antibody conjugates
|
|
US2018346519A1
|
|
Derivatives of gamma-amanitin
|
|
RU2724328C2
|
|
Amathoxine-antibody conjugates
|
